Results 141 to 150 of about 2,619 (179)
Some of the next articles are maybe not open access.
International Journal of Pharmaceutical Quality Assurance
Lornoxicam is available in the market as a solid dosage form, particularly tablets. Liquid chromatography has been the recommended assay procedure for lornoxicam in various pharmacopeias.
M. Puranik +3 more
semanticscholar +1 more source
Lornoxicam is available in the market as a solid dosage form, particularly tablets. Liquid chromatography has been the recommended assay procedure for lornoxicam in various pharmacopeias.
M. Puranik +3 more
semanticscholar +1 more source
Transfersomal gel nanocarriers for enhancement the permeation of lornoxicam
, 2020In respect to the major gastrointestinal disorders associated with oral administration of Lornoxicam, LOR, a potent anti-inflammatory drug, topical delivery could be an alternative route of administration.
Hesham M. Tawfeek +4 more
semanticscholar +1 more source
Lornoxicam in clinical practice.
Postgraduate medical journal, 1991Three studies reported here have confirmed that lornoxicam is effective in osteoarthritis and the ideal dose appears to be 12 mg daily. Overall, lornoxicam appears to be a useful drug in the treatment of both osteo- and rheumatoid arthritis, from the data presently available.
H, Berry, S, Ollier
openaire +1 more source
Formulation and Evaluation of Bilayer Tablets of Lornoxicam for the Management of Pain
Journal of Biomedical and Pharmaceutical ResearchThe aim of present study was to formulate and evaluation of bilayer tablet for management of Pain Contacting Lornoxicam. The Immediate release layer prepared by dry granulation method using sodium starch glycolate, cross povidone, aerosil, magnesium ...
A. Gupta +2 more
semanticscholar +1 more source
Lornoxicam Salts: Crystal Structures, Conformations, and Solubility
Crystal Growth & Design, 2014Lornoxicam (LXM), a nonsteroidal anti-inflammatory drug (NSAID), is an amphiprotic molecule that exists as a zwitterion in the solid state. The formation of two strong intramolecular N+–H···O and N–H···O– hydrogen bonds in a stable six-member ring geometry, S(6), renders this otherwise flexible molecule in a rigid conformation (conformer A).
Kuthuru Suresh, Ashwini Nangia
openaire +1 more source
Pharmacokinetics of lornoxicam in man.
Postgraduate medical journal, 1991Clinical phase I pharmacokinetic studies with lornoxicam were performed with the 4 mg dose of lornoxicam. Lornoxicam was administered as an aqueous solution both orally and intravenously to young, healthy, male volunteers. The total excretion of lornoxicam via urine and faeces after oral administration was determined by administering 14C-labelled ...
G, Hitzenberger +3 more
openaire +1 more source
Clinical pharmacokinetic studies with lornoxicam.
Postgraduate medical journal, 1991Pharmacokinetic data from several studies in young and elderly human subjects are reviewed. Lornoxicam appears to be extensively metabolized and no unchanged drug has been found in the urine. It has a relatively short elimination half-life (about 4 hours), and no significant differences in pharmacokinetic data have been found between young and elderly ...
P, Turner, A, Johnston
openaire +1 more source